4.8 Article

Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo

期刊

JOURNAL OF CONTROLLED RELEASE
卷 349, 期 -, 页码 831-843

出版社

ELSEVIER
DOI: 10.1016/j.jconrel.2022.07.041

关键词

RNA interference; Therapeutic oligonucleotides; siRNA extrahepatic delivery; Lipid conjugation; Endosomal escape; Ionizable lipid

资金

  1. National Institutes of Health [RO1GM10880304, S10 OD020012]

向作者/读者索取更多资源

The study demonstrates the importance of lipid conjugation in improving siRNA endosomal escape and tissue distribution. Modulating the nature of the conjugate can affect the intratissue distribution and non-specific gene modulation of siRNA.
Lipid conjugation supports delivery of small interfering RNAs (siRNAs) to extrahepatic tissues, expanding the therapeutic potential of siRNAs beyond liver indications. However, siRNA silencing efficacy in extrahepatic tissues remains inferior to that routinely achieved in liver, partially due to the low rate of endosomal escape following siRNA internalization. Improving siRNA endosomal release into cytoplasm is crucial to improving efficacy of lipid-conjugated siRNAs. Given the ability of ionizable lipids to enhance endosomal escape in a context of lipid nanoparticles (LNP), here, we provide the first report on the effect of an ionizable lipid conjugate on siRNA endosomal escape, tissue distribution, efficacy, and toxicity in vivo. After developing a synthetic route to covalently attach the ionizable lipid, DLin-MC3-DMA, to siRNAs, we demonstrate that DLin-MC3-DMA en-hances endosomal escape in cell culture without compromising siRNA efficacy. In mice, DLin-MC3-DMA con-jugated siRNAs exhibit a similar overall tissue distribution profile to the similarly hydrophobic cholesterol -conjugated siRNA. However, only DLin-MC3-DMA conjugated siRNAs accumulated in vascular compartments, suggesting an effect of conjugate structure on intratissue distribution. Interestingly, we observed non-specific modulation of gene expression in tissues with high accumulation of DLin-MC3-DMA siRNAs (>20 pmol/mg of tissue) while limited non-specific gene modulation has been observed in tissues with lower siRNA accumulation. These findings suggest modulating the nature of the conjugate is a promising strategy to alter siRNA intratissue and intracellular trafficking. Fine-tuning the nature of the conjugate to optimize endosomal escape while minimizing toxicity will be critical for the progression of therapeutic siRNA applications beyond the liver.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据